Skip directly to content

Our business units

Pfizer works across various different sectors within the UK pharmaceutical industry, including commercial, research and development (R&D), manufacturing, packaging and distribution.

To meet the needs of these diverse sectors, our business is divided into three distinct business units:

Pfizer Biopharmaceuticals Group is committed to discovering, developing, manufacturing and delivering innovative products and vaccines that change the outcome of chronic conditions and devastating diseases.

It comprises six business groups:

  • Hospital
  • Inflammation and immunology
  • Internal medicine (metabolic disease, cardiovascular risk & respiratory health)
  • Oncology
  • Rare disease
  • Vaccines

Pfizer Upjohn focuses on 20 established iconic biopharmaceutical brands across the following therapeutic areas:

  • Cardiovascular
  • Opthalmology
  • Neurology and Pain
  • Psychiatry
  • Urology

Pfizer Consumer Healthcare develops, manufactures and markets leading over-the-counter medicines, vitamins and nutritional products, with some brands that are well-known household names.

The portfolio includes products developed to help consumers cope effectively with everyday healthcare problems such as relieving headaches or joint and back pain to fighting coughs; treatments for dry or itchy skin to vitamin and mineral supplements.


These three business units are underpinned by our Worldwide R&D and Global Supply divisions and the Enabling Functions that advance all of the company’s businesses, organisations and priorities (such as Corporate Affairs, Legal, HR and Business Technology).


PP-PFE-GBR-1736 / May 2019